Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-10

Clinical Trial Update: CANNAbinoids in the Treatment of TICS (CANNA-TICS) [Phase 3]

View source ↗

Summary

Phase 3 trial update for cannabinoids in Tourette syndrome and tic disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hannover Medical School | Conditions: Tourette Syndrome, Tic Disorders | Phase 3 | Status: COMPLETED